Basic Information
SYNTHAMIN 17 WITHOUT ELECTROLYTES 10% AMINO ACID INTRAVENOUS INFUSION
INJECTION
Regulatory Information
SIN09992P
September 15, 1998
General Sale List
Therapeutic
INTRAVENOUS
August 10, 2023
May 30, 2025
XB05BA01
Company Information
Active Ingredients
Strength: 0.40 g/l
Strength: 5.80 g/l
Strength: 5.60 g/l
Strength: 6.00 g/l
Strength: 5.00 g/l
Strength: 5.80 g/l
Strength: 4.00 g/l
Strength: 10.30 g/l
Strength: 1.80 g/l
Strength: 4.80 g/l
Strength: 11.50 g/l
Strength: 6.80 g/l
Strength: 7.30 g/l
Strength: 4.20 g/l
Strength: 20.70 g/l
Detailed Information
Contraindications
**Contraindications** Synthamin is contraindicated in patients with: - Known hypersensitivity to any of the active substances or excipients, or to components of the container - Congenital abnormality of amino acid metabolism
Indication Information
**Therapeutic indications** Synthamin 17, 10.0% Amino Acid Intravenous Infusion without Electrolytes provides a biologically available source of nitrogen (L-amino acids) for amino acids synthesis. When administered with an adequate source of energy such as concentrated carbohydrate solutions, minerals and vitamins, the mixture provides (with the exception of essential fatty acids) sufficient parenteral nutrition for patients unable to absorb adequate oral nutrition.